This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Les Laboratoires Servier, Vernalis &r&d) Ltd.. Active years: 2024.
Company Filing History:


Years Active: 2024
Title: Emilie De Baets: Innovator in Pharmaceutical Chemistry
Introduction
Emilie De Baets is a notable inventor based in Notre Dame de Bondeville, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. Her work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Emilie holds a patent for "Crystalline forms of a MCL-1 inhibitor, a process for their preparation and pharmaceutical compositions containing them." This patent specifically focuses on the crystalline forms of Compound A, which has potential applications in treating various diseases. She has successfully secured 1 patent that highlights her innovative approach to drug development.
Career Highlights
Throughout her career, Emilie has worked with prominent organizations, including Les Laboratoires Servier and Vernalis R&D Ltd. Her experience in these companies has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry. Emilie's work is characterized by her commitment to improving therapeutic options for patients.
Collaborations
Emilie has collaborated with talented individuals in her field, including Julien Auvray and Michael Lynch. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Emilie De Baets is a remarkable inventor whose contributions to pharmaceutical chemistry are noteworthy. Her patent on MCL-1 inhibitors exemplifies her innovative spirit and dedication to advancing medical research. Through her work and collaborations, she continues to make a significant impact in the field.